Literature DB >> 16476188

Vaccination and anaphylaxis.

Hanne Nokleby1.   

Abstract

The incidence of anaphylactic or severe allergic reactions to vaccines is very low, less than one case per million vaccine doses. Larger studies from later years report no deaths. The cause of the reaction is usually not the immunizing antigen itself, but rather some other vaccine ingredient such as egg protein from the production process or gelatin added as a stabilizer. Most people with egg allergy can be vaccinated without any reaction. Vasovagal reactions with or without hyperventilation are common after vaccination. They can be rather dramatic and are often mistaken for anaphylactic reactions. Correct diagnosis is important in making it possible to vaccinate those who might otherwise run the risk of serious infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476188     DOI: 10.1007/s11882-006-0003-x

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  30 in total

1.  Anaphylaxis from yellow fever vaccine.

Authors:  J M Kelso; G T Mootrey; T F Tsai
Journal:  J Allergy Clin Immunol       Date:  1999-04       Impact factor: 10.793

Review 2.  Immediate allergic reactions after vaccinations--a post-marketing surveillance review.

Authors:  Olaf Zent; Cornelia Arras-Reiter; Michael Broeker; Renald Hennig
Journal:  Eur J Pediatr       Date:  2002-01       Impact factor: 3.183

3.  Current issues with influenza vaccination in egg allergy.

Authors:  Robert S Zeiger
Journal:  J Allergy Clin Immunol       Date:  2002-12       Impact factor: 10.793

4.  Vaccination despite thimerosal sensitivity.

Authors:  W Aberer
Journal:  Contact Dermatitis       Date:  1991-01       Impact factor: 6.600

5.  Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.

Authors:  Vitali Pool; M Miles Braun; John M Kelso; Gina Mootrey; Robert T Chen; John W Yunginger; Robert M Jacobson; Paul M Gargiullo
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

6.  Safe administration of influenza vaccine to patients with egg allergy.

Authors:  J M James; R S Zeiger; M R Lester; M B Fasano; J E Gern; L E Mansfield; H J Schwartz; H A Sampson; H H Windom; S B Machtinger; S Lensing
Journal:  J Pediatr       Date:  1998-11       Impact factor: 4.406

7.  Measles immunization in children with a history of egg allergy.

Authors:  D N Baxter
Journal:  Vaccine       Date:  1996-02       Impact factor: 3.641

8.  A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.

Authors:  T Nakayama; C Aizawa; H Kuno-Sakai
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

Review 9.  Vaccination and allergy.

Authors:  Menachem Rottem; Yehuda Shoenfeld
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-06       Impact factor: 2.064

10.  Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS).

Authors:  Michelle Russell; Vitali Pool; John M Kelso; Vesna J Tomazic-Jezic
Journal:  Vaccine       Date:  2004-12-16       Impact factor: 3.641

View more
  8 in total

1.  Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.

Authors:  Holly J Corbett; Germain J P Fernando; Xianfeng Chen; Ian H Frazer; Mark A F Kendall
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

2.  Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery.

Authors:  Akihiko Ono; Sayami Ito; Shun Sakagami; Hideo Asada; Mio Saito; Ying-Shu Quan; Fumio Kamiyama; Sachiko Hirobe; Naoki Okada
Journal:  Pharmaceutics       Date:  2017-08-03       Impact factor: 6.321

Review 3.  Vaccination and anaphylaxis: a forensic perspective.

Authors:  Cristian Palmiere; Camilla Tettamanti; Maria Pia Scarpelli
Journal:  Croat Med J       Date:  2017-02-28       Impact factor: 1.351

4.  Knowledge, Perceptions, and Practice of Nurses on Surveillance of Adverse Events following Childhood Immunization in Nairobi, Kenya.

Authors:  Calistus Wanjala Masika; Harrysone Atieli; Tom Were
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

Review 5.  Adverse events of vaccines and the consequences of non-vaccination: a critical review.

Authors:  Luana Raposo de Melo Moraes Aps; Marco Aurélio Floriano Piantola; Sara Araujo Pereira; Julia Tavares de Castro; Fernanda Ayane de Oliveira Santos; Luís Carlos de Souza Ferreira
Journal:  Rev Saude Publica       Date:  2018-04-12       Impact factor: 2.106

Review 6.  COVID-19 vaccines: Frequently asked questions and updated answers.

Authors:  M Lefebvre; N Vignier; B Pitard; E Botelho-Nevers; B Wyplosz; R Cohen; O Epaulard
Journal:  Infect Dis Now       Date:  2021-02-27

7.  Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?

Authors:  Salvatore Chirumbolo
Journal:  J Med Virol       Date:  2021-03-25       Impact factor: 20.693

8.  Maternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  M Patwardhan; L O Eckert; H Spiegel; F Pourmalek; C Cutland; S Kochhar; B Gonik
Journal:  Vaccine       Date:  2016-07-15       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.